Julie Steele

Statistics

Publications

Citations

1.1K

H-Index

Active since

2004

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Fondazione IRCCS Istituto Neurologico Carlo Besta

University of Miami

International University of Health and Welfare

University of North Carolina at Chapel Hill

Julie Steele is an author at Alexion Pharmaceuticals (United States) specializing in medicine, myasthenia gravis pharmacotherapy, and anti-acetylcholine receptor antibodies.

Publications per year

2004–2020

Publications

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Motor neuron involvement in multisystem proteinopathy

Michael Benatar, Joanne Wuu, Catalina Fernandez et al. · Neurology · 2013 · 97 citations · Full text

Medicine, Genetics, Neurology +17

Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis

Ashok Verma, Julie Steele · Muscle & Nerve · 2006 · 82 citations

Medicine, Neurology, Neuroscience +14

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 7